Scientists discover that the CD74 protein could predict the effectiveness of immunotherapy, advancing colon cancer treatment.

About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of ...

A group of 18 colorectal cancer patients experienced complete remission after taking the experimental drug dostarlimab for ...

Jan. 28, 2025 — A data analysis from a randomized clinical trial for stage 3 colon cancer patients found that patients with evidence of residual cancer in their blood after surgery to remove the ...

Data presented at the ASCO Gastrointestinal Cancers Symposium showed the regimen may be a new option, but it comes with more treatment and financial toxicity.

The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval ...

Marwan G. Fakih, MD, discussed the implications of the findings from the phase 2 study for patients with microsatellite ...

Bristol Myers Squibb’s (BMS) dual immunotherapy combination has been recommended by the European Medicines Agency’s human ...

VMPL Hyderabad Telangana [India] February 4 On World Cancer Day Dr Sharat Chandra Goteti one of the top medical oncologists ...

The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic ...

In recognition of World Cancer Day, The Princess Margaret Cancer Foundation (PMCF) is proud to launch Carry The Fire, its ...